1. Home
  2. IDCC vs CYTK Comparison

IDCC vs CYTK Comparison

Compare IDCC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InterDigital Inc.

IDCC

InterDigital Inc.

HOLD

Current Price

$362.24

Market Cap

8.9B

Sector

Miscellaneous

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.11

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDCC
CYTK
Founded
1972
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
7.6B
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
IDCC
CYTK
Price
$362.24
$63.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
19
Target Price
$412.50
$89.26
AVG Volume (30 Days)
252.7K
1.4M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
N/A
EPS
11.80
N/A
Revenue
$307,404,000.00
$13,368,000.00
Revenue This Year
N/A
$7.37
Revenue Next Year
$3.38
$310.19
P/E Ratio
$30.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$195.41
$29.31
52 Week High
$412.60
$70.98

Technical Indicators

Market Signals
Indicator
IDCC
CYTK
Relative Strength Index (RSI) 55.59 42.97
Support Level $350.35 $59.12
Resistance Level $365.98 $64.22
Average True Range (ATR) 12.25 2.12
MACD 1.27 -0.46
Stochastic Oscillator 45.29 22.37

Price Performance

Historical Comparison
IDCC
CYTK

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: